Skip to content

Home-based vs. Supervised Exercise for People With Claudication

Home-based vs. Supervised Exercise for Claudicants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00618670
Enrollment
135
Registered
2008-02-20
Start date
2006-09-30
Completion date
2016-09-30
Last updated
2018-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Claudication

Keywords

aging, gait, musculoskeletal disorder therapy, peripheral blood vessel disorder, muscle function, muscle strength, quality of life

Brief summary

The purpose of this study is to examine the effects of a home-based exercise rehabilitation program compared to a supervised exercise program on intermittent claudication (leg pain or discomfort) and ambulatory function.

Detailed description

This study seeks to 1) compare the changes in ambulatory function, vascular function, and health-related quality of life in patients limited by intermittent claudication following a home-based exercise rehabilitation program, a supervised exercise program, and a light resistance training exercise program; and 2) determine whether changes in walking efficiency, calf muscle circulation, and calf muscle oxygen are the reasons by which both home-based and supervised exercise rehabilitation improve ambulatory function. We hypothesize that a home-based exercise program utilizing new physical activity monitoring technology that can accurately quantify exercise adherence as well as the intensity, duration, and volume of exercise sessions will result in similar changes in ambulatory function, vascular function, and health-related quality of life compared to a standard, supervised exercise program. Further, both the home-based and supervised exercise rehabilitation programs will result in greater changes in ambulatory function, vascular function, and health-related quality of life than a light resistance training exercise program. Finally, we hypothesize that the changes in walking efficiency, calf muscle circulation, and calf muscle oxygen will each be predictive of improved ambulation following the home-based exercise program as well as the supervised exercise program. The 3-month program will consist of walking 3 times per week, with progressive increases in duration and intensity. The two walking exercise programs will be matched on the estimated caloric expenditure during the training sessions. Patients in the control group will perform light resistance training without any walking exercise.

Interventions

BEHAVIORALWalking Exercise

Three times per week for 3 months

BEHAVIORALControl--Resistance Training

Three times per week for 3 months

Sponsors

Oklahoma Center for the Advancement of Science and Technology
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Positive history of intermittent claudication assessed by the San Diego Claudication Questionnaire * Exercise limited by intermittent claudication during a screening treadmill test using the Gardner protocol * Ankle/brachial index (ABI) less than 0.90 at rest, which decreases to less than 0.73 immediately following the treadmill exercise test

Exclusion criteria

* Absence of PAD (peripheral artery disease) * Asymptomatic PAD (Fontaine stage I) * Rest pain due to PAD (Fontaine stage III) * Tissue loss due to PAD (Fontaine stage IV) * Medical conditions that are contraindicative for exercise according to the American College of Sports Medicine (e.g., acute myocardial infarction, unstable angina, etc.) * Cognitive dysfunction (mini-mental state examination score less than 24)

Design outcomes

Primary

MeasureTime frame
Change in the walking distance to onset of leg pain, and the change in walking distance to maximal leg pain3 months

Secondary

MeasureTime frame
Change in walking efficiency3 months
Change in calf muscle circulation and calf muscle oxygen3 months
Change in health-related quality of life3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026